mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
TG-100-115 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.003 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
0.17 |
0.004 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.004 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.004 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.005 |